What is the recommended duration and first‑line regimen for Helicobacter pylori eradication therapy?

H. pylori Eradication Therapy Duration

The recommended duration for H. pylori eradication therapy is 14 days for all first-line regimens, regardless of which specific regimen is used. 1, 2, 3

Standard Treatment Duration

• 14 days is the mandatory duration for bismuth quadruple therapy, concomitant non-bismuth quadruple therapy, clarithromycin triple therapy, levofloxacin triple therapy, and all rescue regimens. 1, 2, 3

• Extending therapy from 7 to 14 days improves eradication success by approximately 5%, which translates to a clinically meaningful increase in cure rates from roughly 75% to 80-85%. 1, 2, 4

• The Toronto Consensus, Maastricht V/Florence Consensus, and American College of Gastroenterology all uniformly endorse 14 days as the standard duration to maximize first-attempt success and avoid the need for retreatment. 1, 2

First-Line Regimen Recommendations

Bismuth Quadruple Therapy (Preferred)

• High-dose PPI twice daily + bismuth subsalicylate 262 mg (2 tablets) four times daily + metronidazole 500 mg three to four times daily + tetracycline 500 mg four times daily for 14 days. 1, 2, 3

• This regimen achieves 80-90% eradication rates even in areas with high clarithromycin and metronidazole resistance (>15-20%). 1, 2, 3

• Bismuth has no documented bacterial resistance, and its synergistic effect overcomes metronidazole resistance in vitro. 1, 2

Alternative When Bismuth Unavailable

• Concomitant non-bismuth quadruple therapy: High-dose PPI twice daily + amoxicillin 1000 mg twice daily + clarithromycin 500 mg twice daily + metronidazole 500 mg twice daily for 14 days. 1, 2, 3

• This should only be used in regions where clarithromycin resistance is documented to be <15%. 1, 2

Critical Optimization Factors

• High-dose PPI (esomeprazole or rabeprazole 40 mg) twice daily is strongly preferred over standard-dose PPIs, as it increases cure rates by 8-12%. 1, 2, 3

• PPIs must be taken 30 minutes before meals on an empty stomach, without concomitant antacids. 1, 2, 5

• Never shorten therapy below 14 days—doing so reduces eradication success by approximately 5% and is a common cause of treatment failure. 1, 2, 4

Duration Comparisons from Evidence

• Meta-analysis of 45 studies comparing 7-day versus 14-day PPI triple therapy showed eradication rates of 72.9% versus 81.9% (RR 0.66, NNT 11). 1, 4

• For 10-day versus 7-day therapy, eradication rates were 79.9% versus 75.7% (RR 0.80, NNT 21). 1, 4

• For 14-day versus 10-day therapy, eradication rates were 84.4% versus 78.5% (RR 0.72, NNT 17). 1, 4

Second-Line Therapy Duration

• After first-line failure, all second-line regimens (bismuth quadruple therapy if not previously used, or levofloxacin triple therapy) must also be given for 14 days. 1, 2, 3

• Levofloxacin triple therapy: High-dose PPI twice daily + amoxicillin 1000 mg twice daily + levofloxacin 500 mg once daily for 14 days. 1, 2, 3

Rescue Therapy Duration

• Rifabutin triple therapy: Rifabutin 150 mg twice daily + amoxicillin 1000 mg twice daily + high-dose PPI twice daily for 14 days. 1, 2, 3

• High-dose dual therapy: Amoxicillin 2-3 grams daily in 3-4 divided doses + high-dose PPI twice daily for 14 days. 1, 2, 3

Common Pitfalls to Avoid

• Do not use 7-day regimens—they are associated with unacceptably low eradication rates of approximately 70-75% in contemporary practice. 1, 4, 6

• Do not assume 10 days is adequate—while 10-day therapy is marginally better than 7 days, it still falls short of the 14-day standard by roughly 5%. 1, 4

• Avoid pantoprazole as the PPI choice, as 40 mg pantoprazole provides acid suppression equivalent to only 9 mg omeprazole. 2

Verification of Eradication

• Confirm eradication with urea breath test or monoclonal stool antigen test at least 4 weeks after completing therapy and at least 2 weeks after discontinuing PPIs. 1, 2, 3

• Never use serology for test-of-cure, as antibodies persist long after successful eradication. 2